Literature DB >> 26289026

MT1-MMP recognition by ERM proteins and its implication in CD44 shedding.

Shin-Ichi Terawaki1, Ken Kitano1, Miki Aoyama1, Tomoyuki Mori1, Toshio Hakoshima1.   

Abstract

Membrane type 1-matrix metalloproteinase (MT1-MMP) is a key enzyme involved in tumor cell invasion by shedding their cell-surface receptor CD44 anchored with F-actin through ezrin/radixin/moesin (ERM) proteins. We found the cytoplasmic tail of MT1-MMP directly binds the FERM domain of radixin, suggesting F-actin-based recruitment of MT1-MMP to CD44 for invasion. Our crystal structure shows that the central region of the MT1-MMP cytoplasmic tail binds subdomain A of the FERM domain, and makes an antiparallel β-β interaction with β2A-strand. This binding mode is distinct from the previously determined binding mode of CD44 to subdomain C. We showed that radixin simultaneously binds both MT1-MMP and CD44, indicating ERM protein-mediated colocalization of MT1-MMP and its substrate CD44 and anchoring to F-actin. Our study implies that ERM proteins contribute toward accelerated CD44 shedding by MT1-MMP through ERM protein-mediated interactions between their cytoplasmic tails.
© 2015 The Authors Genes to Cells published by Molecular Biology Society of Japan and Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26289026     DOI: 10.1111/gtc.12276

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  6 in total

Review 1.  Membrane-anchored proteases in endothelial cell biology.

Authors:  Toni M Antalis; Gregory D Conway; Raymond J Peroutka; Marguerite S Buzza
Journal:  Curr Opin Hematol       Date:  2016-05       Impact factor: 3.284

Review 2.  Contribution of the plasma and lymph Degradome and Peptidome to the MHC Ligandome.

Authors:  Laura Santambrogio; Hans-Georg Rammensee
Journal:  Immunogenetics       Date:  2018-10-20       Impact factor: 2.846

3.  Regulation of MT1-MMP Activity through Its Association with ERMs.

Authors:  Henar Suárez; Soraya López-Martín; Victor Toribio; Moreno Zamai; María Victoria Hernández-Riquer; Laura Genís; Alicia García Arroyo; María Yáñez-Mó
Journal:  Cells       Date:  2020-02-03       Impact factor: 6.600

4.  Chemoresistance Transmission via Exosome-Transferred MMP14 in Pancreatic Cancer.

Authors:  Xinyuan Li; Kai Li; Mengmeng Li; Xiaoyu Lin; Yu Mei; Xuemei Huang; Huanjie Yang
Journal:  Front Oncol       Date:  2022-02-09       Impact factor: 6.244

Review 5.  Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP.

Authors:  Gérard Zalcman; Guénaëlle Levallet; Fatéméh Dubois; Céline Bazille; Jérôme Levallet; Elodie Maille; Solenn Brosseau; Jeannick Madelaine; Emmanuel Bergot
Journal:  Target Oncol       Date:  2022-07-30       Impact factor: 4.864

6.  Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5+ colorectal cancer.

Authors:  Haoran Feng; Kun Liu; Xiaonan Shen; Juyong Liang; Changgang Wang; Weihua Qiu; Xi Cheng; Ren Zhao
Journal:  Cell Death Dis       Date:  2020-10-24       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.